Human Health Holdings Limited (Stock Code: 1419) has released a circular detailing several key proposals, including general mandates for share issuance and repurchases, the re-election of two directors, the re-appointment of its auditor, and plans to terminate its 2016 Share Option Scheme in favor of a new framework. The board has also recommended a final dividend of HK$0.03 per share for the financial year ended 30 June 2025.

An annual general meeting is scheduled for 10 December 2025 at 11:30 a.m. Shareholders listed on the register from 5 December to 10 December 2025 may attend and vote at the meeting. The record date for the final dividend is set for 18 December 2025, with payment expected around 5 January 2026. The register of members will be closed from 17 December to 18 December 2025 for determining dividend eligibility.

Included in the proposals is a general mandate for issuing up to 20% of the issued share capital, excluding any treasury shares, and repurchasing up to 10% of issued shares. Subject to approval at the meeting, any repurchased shares may either be canceled or held as treasury shares. Directors seeking re-election include one executive and one independent non-executive member, and the new Share Option Scheme would replace the 2016 version. The agenda also covers the separate approval of a service provider sub-limit for the new scheme and the setting of performance or vesting requirements for future grants.